WASHINGTON, DC – The National Venture Capital Association (NVCA) today issued the following statement after the House of Representatives passed H.R. 160, the Protect Medical Innovation Act of 2015, introduced by Reps. Erik Paulsen (R-MN) and Ron Kind (D-WI).
“The U.S. has been the global leader in the development of medical device innovation for the last three decades. However, the imposition of the medical device tax has been a massive burden on the sector and has significantly damaged our competitive advantage,” said Bobby Franklin, President and CEO of NVCA. Read more